Industry Research Reports

Home > Reports > Service & Software > Global and United States AI-based Antibody Development Platform Market Report & Forecast 2024-2030

Global and United States AI-based Antibody Development Platform Market Report & Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-06-15

Pages: 101 Pages

Report ld: 3197384

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.

The global AI-based Antibody Development Platform revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In United States the AI-based Antibody Development Platform revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States AI-based Antibody Development Platform market, also covers the segmentation data of other regions in regional level and county level.

The global key players of AI-based Antibody Development Platform include Kyinno Biotechnolog, XtalPi Inc, DenovAI Biotech, immunitoAI Private Limited, EVQLV, Creative Biolabs, etc. The global five biggest players hold a share of % in 2023.

Global AI-based Antibody Development Platform Scope and Market Size

AI-based Antibody Development Platform market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global AI-based Antibody Development Platform market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the AI-based Antibody Development Platform market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

Kyinno Biotechnolog
XtalPi Inc
DenovAI Biotech
immunitoAI Private Limited
EVQLV
Creative Biolabs

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Antibody Generation and Screening
Discovery and Target Recognition
Engineering and Optimization
Other

Segment by Application

Pharmaceutical
Biotechnology
Academic Research
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces AI-based Antibody Development Platform definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of AI-based Antibody Development Platform companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue of AI-based Antibody Development Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 6: Americas by Type, by Application and by country, revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Antibody Development Platform revenue, gross margin, and recent development, etc.

Chapter 11: Analyst's Viewpoints/Conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 AI-based Antibody Development Platform Product Introduction

1.2 Global AI-based Antibody Development Platform Outlook, 2019 VS 2023 VS 2030

1.2.1 Global AI-based Antibody Development Platform Market Size for the Year 2019-2030

1.2.2 United States AI-based Antibody Development Platform Market Size for the Year 2019-2030

1.3 AI-based Antibody Development Platform Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.3.1 The Market Share of United States AI-based Antibody Development Platform in Global, 2019 VS 2023 VS 2030

1.3.2 The Growth Rate of AI-based Antibody Development Platform Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4 AI-based Antibody Development Platform Market Dynamics

1.4.1 AI-based Antibody Development Platform Industry Trends

1.4.2 AI-based Antibody Development Platform Market Drivers

1.4.3 AI-based Antibody Development Platform Market Challenges

1.4.4 AI-based Antibody Development Platform Market Restraints

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 AI-based Antibody Development Platform by Type

2.1 AI-based Antibody Development Platform Market by Type

2.1.1 Antibody Generation and Screening

2.1.2 Discovery and Target Recognition

2.1.3 Engineering and Optimization

2.1.4 Other

2.2 Global AI-based Antibody Development Platform Market Size by Type (2019, 2023 & 2030)

2.3 Global AI-based Antibody Development Platform Market Size by Type (2019-2030)

2.4 United States AI-based Antibody Development Platform Market Size by Type (2019, 2023 & 2030)

2.5 United States AI-based Antibody Development Platform Market Size by Type (2019-2030)

3 AI-based Antibody Development Platform by Application

3.1 AI-based Antibody Development Platform Market by Application

3.1.1 Pharmaceutical

3.1.2 Biotechnology

3.1.3 Academic Research

3.1.4 Others

3.2 Global AI-based Antibody Development Platform Market Size, by Application (2019, 2023 & 2030)

3.3 Global AI-based Antibody Development Platform Market Size by Application (2019-2030)

3.4 United States AI-based Antibody Development Platform Market Size by Application (2019, 2023 & 2030)

3.5 United States AI-based Antibody Development Platform Market Size by Application (2019-2030)

4 Global AI-based Antibody Development Platform Competitor Landscape by Company

4.1 Global AI-based Antibody Development Platform Market Size by Company

4.1.1 Global Key Companies of AI-based Antibody Development Platform, Ranked by Revenue (2023)

4.1.2 Global AI-based Antibody Development Platform Revenue by Player (2019-2024)

4.2 Global AI-based Antibody Development Platform Concentration Ratio (CR)

4.2.1 AI-based Antibody Development Platform Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Companies of AI-based Antibody Development Platform in 2023

4.2.3 Global AI-based Antibody Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Players of AI-based Antibody Development Platform Head office and Area Served

4.4 Global Key Players of AI-based Antibody Development Platform, Product and Application

4.5 Global Key Players of AI-based Antibody Development Platform, Date of Enter into This Industry

4.6 Companies Mergers & Acquisitions, Expansion Plans

4.7 United States AI-based Antibody Development Platform Market Size by Company

4.7.1 Key Players of AI-based Antibody Development Platform in United States, Ranked by Revenue (2023)

4.7.2 United States AI-based Antibody Development Platform Revenue by Players (2022, 2023 & 2024)

5 Global AI-based Antibody Development Platform Market Size by Region

5.1 Global AI-based Antibody Development Platform Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global AI-based Antibody Development Platform Market Size by Region (2019-2030)

5.2.1 Global AI-based Antibody Development Platform Market Size by Region: 2019-2024

5.2.2 Global AI-based Antibody Development Platform Market Size by Region: 2025-2030

6 Americas

6.1 Americas AI-based Antibody Development Platform Market Size YoY Growth 2019-2030

6.2 Americas AI-based Antibody Development Platform Market Size by Type

6.2.1 Americas AI-based Antibody Development Platform Market Size by Type (2019-2024)

6.2.2 Americas AI-based Antibody Development Platform Market Size by Type (2025-2030)

6.2.3 Americas AI-based Antibody Development Platform Market Share by Type (2019-2030)

6.3 Americas AI-based Antibody Development Platform Market Size by Application

6.3.1 Americas AI-based Antibody Development Platform Market Size by Application (2019-2024)

6.3.2 Americas AI-based Antibody Development Platform Market Size by Application (2025-2030)

6.3.3 Americas AI-based Antibody Development Platform Market Share by Application (2019-2030)

6.4 Americas AI-based Antibody Development Platform Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 United States

6.4.2 Canada

6.4.3 Mexico

6.4.4 Brazil

7 EMEA

7.1 EMEA AI-based Antibody Development Platform Market Size YoY Growth 2019-2030

7.2 EMEA AI-based Antibody Development Platform Market Size by Type

7.2.1 EMEA AI-based Antibody Development Platform Market Size by Type (2019-2024)

7.2.2 EMEA AI-based Antibody Development Platform Market Size by Type (2025-2030)

7.2.3 EMEA AI-based Antibody Development Platform Market Share by Type (2019-2030)

7.3 EMEA AI-based Antibody Development Platform Market Size by Application

7.3.1 EMEA AI-based Antibody Development Platform Market Size by Application (2019-2024)

7.3.2 EMEA AI-based Antibody Development Platform Market Size by Application (2025-2030)

7.3.3 EMEA AI-based Antibody Development Platform Market Share by Application (2019-2030)

7.4 EMEA AI-based Antibody Development Platform Market Facts & Figures by Region (2019, 2023 & 2030)

7.4.1 Europe

7.4.2 Middle East

7.4.3 Africa

8 China

8.1 China AI-based Antibody Development Platform Market Size by Type

8.1.1 China AI-based Antibody Development Platform Market Size by Type (2019-2024)

8.1.2 China AI-based Antibody Development Platform Market Size by Type (2025-2030)

8.1.3 China AI-based Antibody Development Platform Market Share by Type (2019-2030)

8.2 China AI-based Antibody Development Platform Market Size by Application

8.2.1 China AI-based Antibody Development Platform Market Size by Application (2019-2024)

8.2.2 China AI-based Antibody Development Platform Market Size by Application (2025-2030)

8.2.3 China AI-based Antibody Development Platform Market Share by Application (2019-2030)

9 APAC (excluding China)

9.1 APAC AI-based Antibody Development Platform Market Size YoY Growth 2019-2030

9.2 APAC AI-based Antibody Development Platform Market Size by Type

9.2.1 APAC AI-based Antibody Development Platform Market Size by Type (2019-2024)

9.2.2 APAC AI-based Antibody Development Platform Market Size by Type (2025-2030)

9.2.3 APAC AI-based Antibody Development Platform Market Share by Type (2019-2030)

9.3 APAC AI-based Antibody Development Platform Market Size by Application

9.3.1 APAC AI-based Antibody Development Platform Market Size by Application (2019-2024)

9.3.2 APAC AI-based Antibody Development Platform Market Size by Application (2025-2030)

9.3.3 APAC AI-based Antibody Development Platform Market Share by Application (2019-2030)

9.4 APAC AI-based Antibody Development Platform Market Facts & Figures by Region (2019, 2023 & 2030)

9.4.1 Japan

9.4.2 South Korea

9.4.3 China Taiwan

9.4.4 ASEAN

9.4.5 India

10 Key Players Profiles

10.1 Kyinno Biotechnolog

10.1.1 Kyinno Biotechnolog Company Details

10.1.2 Kyinno Biotechnolog Business Overview

10.1.3 Kyinno Biotechnolog AI-based Antibody Development Platform Introduction

10.1.4 Kyinno Biotechnolog Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.1.5 Kyinno Biotechnolog Recent Development

10.2 XtalPi Inc

10.2.1 XtalPi Inc Company Details

10.2.2 XtalPi Inc Business Overview

10.2.3 XtalPi Inc AI-based Antibody Development Platform Introduction

10.2.4 XtalPi Inc Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.2.5 XtalPi Inc Recent Development

10.3 DenovAI Biotech

10.3.1 DenovAI Biotech Company Details

10.3.2 DenovAI Biotech Business Overview

10.3.3 DenovAI Biotech AI-based Antibody Development Platform Introduction

10.3.4 DenovAI Biotech Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.3.5 DenovAI Biotech Recent Development

10.4 immunitoAI Private Limited

10.4.1 immunitoAI Private Limited Company Details

10.4.2 immunitoAI Private Limited Business Overview

10.4.3 immunitoAI Private Limited AI-based Antibody Development Platform Introduction

10.4.4 immunitoAI Private Limited Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.4.5 immunitoAI Private Limited Recent Development

10.5 EVQLV

10.5.1 EVQLV Company Details

10.5.2 EVQLV Business Overview

10.5.3 EVQLV AI-based Antibody Development Platform Introduction

10.5.4 EVQLV Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.5.5 EVQLV Recent Development

10.6 Creative Biolabs

10.6.1 Creative Biolabs Company Details

10.6.2 Creative Biolabs Business Overview

10.6.3 Creative Biolabs AI-based Antibody Development Platform Introduction

10.6.4 Creative Biolabs Revenue in AI-based Antibody Development Platform Business (2019-2024)

10.6.5 Creative Biolabs Recent Development

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI-based Antibody Development Platform Market Size, United States VS Global, CAGR (2019 VS 2023 VS 2030)

Table 2. AI-based Antibody Development Platform Market Trends

Table 3. AI-based Antibody Development Platform Market Drivers

Table 4. AI-based Antibody Development Platform Market Challenges

Table 5. AI-based Antibody Development Platform Market Restraints

Table 6. Global AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States AI-based Antibody Development Platform Market Size by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States AI-based Antibody Development Platform Market Size by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Companies of AI-based Antibody Development Platform, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global AI-based Antibody Development Platform Revenue by Player, (US$ Million), 2019-2024

Table 12. Global AI-based Antibody Development Platform Revenue Share by Player, 2019-2024

Table 13. Global AI-based Antibody Development Platform Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global AI-based Antibody Development Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Antibody Development Platform as of 2023)

Table 15. Global Key Players of AI-based Antibody Development Platform, Headquarters and Area Served

Table 16. Global Key Players of AI-based Antibody Development Platform, Product and Application

Table 17. Global Key Players of AI-based Antibody Development Platform, Date of Enter into This Industry

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Key Players of AI-based Antibody Development Platform in United States, Ranked by Revenue (2023) & (US$ Million)

Table 20. United States AI-based Antibody Development Platform Revenue by Players, (US$ Million), 2022, 2023 & 2024

Table 21. United States AI-based Antibody Development Platform Revenue Share by Players, 2022, 2023 & 2024

Table 22. Global AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 23. Global AI-based Antibody Development Platform Market Size by Region (2019-2024) & (US$ Million)

Table 24. Global AI-based Antibody Development Platform Market Size Forecast by Region (2025-2030) & (US$ Million)

Table 25. Americas AI-based Antibody Development Platform Market Size by Type (2019-2024) & (US$ Million)

Table 26. Americas AI-based Antibody Development Platform Market Size by Type (2025-2030) & (US$ Million)

Table 27. Americas AI-based Antibody Development Platform Market Size by Application (2019-2024) & (US$ Million)

Table 28. Americas AI-based Antibody Development Platform Market Size by Application (2025-2030) & (US$ Million)

Table 29. Americas AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 30. Americas AI-based Antibody Development Platform Market Size by Country (2019-2024) & (US$ Million)

Table 31. Americas AI-based Antibody Development Platform Market Size by Country (2025-2030) & (US$ Million)

Table 32. EMEA AI-based Antibody Development Platform Market Size by Type (2019-2024) & (US$ Million)

Table 33. EMEA AI-based Antibody Development Platform Market Size by Type (2025-2030) & (US$ Million)

Table 34. EMEA AI-based Antibody Development Platform Market Size by Application (2019-2024) & (US$ Million)

Table 35. EMEA AI-based Antibody Development Platform Market Size by Application (2025-2030) & (US$ Million)

Table 36. EMEA AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 37. EMEA AI-based Antibody Development Platform Market Size by Region (2019-2024) & (US$ Million)

Table 38. EMEA AI-based Antibody Development Platform Market Size by Region (2025-2030) & (US$ Million)

Table 39. China AI-based Antibody Development Platform Market Size by Type (2019-2024) & (US$ Million)

Table 40. China AI-based Antibody Development Platform Market Size by Type (2025-2030) & (US$ Million)

Table 41. China AI-based Antibody Development Platform Market Size by Application (2019-2024) & (US$ Million)

Table 42. China AI-based Antibody Development Platform Market Size by Application (2025-2030) & (US$ Million)

Table 43. APAC AI-based Antibody Development Platform Market Size by Type (2019-2024) & (US$ Million)

Table 44. APAC AI-based Antibody Development Platform Market Size by Type (2025-2030) & (US$ Million)

Table 45. APAC AI-based Antibody Development Platform Market Size by Application (2019-2024) & (US$ Million)

Table 46. APAC AI-based Antibody Development Platform Market Size by Application (2025-2030) & (US$ Million)

Table 47. APAC AI-based Antibody Development Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 48. APAC AI-based Antibody Development Platform Market Size by Region (2025-2030) & (US$ Million)

Table 49. APAC AI-based Antibody Development Platform Market Size by Region (2025-2030) & (US$ Million)

Table 50. Kyinno Biotechnolog Company Details

Table 51. Kyinno Biotechnolog Business Overview

Table 52. Kyinno Biotechnolog AI-based Antibody Development Platform Product

Table 53. Kyinno Biotechnolog Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 54. Kyinno Biotechnolog Recent Development

Table 55. XtalPi Inc Company Details

Table 56. XtalPi Inc Business Overview

Table 57. XtalPi Inc AI-based Antibody Development Platform Product

Table 58. XtalPi Inc Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 59. XtalPi Inc Recent Development

Table 60. DenovAI Biotech Company Details

Table 61. DenovAI Biotech Business Overview

Table 62. DenovAI Biotech AI-based Antibody Development Platform Product

Table 63. DenovAI Biotech Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 64. DenovAI Biotech Recent Development

Table 65. immunitoAI Private Limited Company Details

Table 66. immunitoAI Private Limited Business Overview

Table 67. immunitoAI Private Limited AI-based Antibody Development Platform Product

Table 68. immunitoAI Private Limited Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 69. immunitoAI Private Limited Recent Development

Table 70. EVQLV Company Details

Table 71. EVQLV Business Overview

Table 72. EVQLV AI-based Antibody Development Platform Product

Table 73. EVQLV Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 74. EVQLV Recent Development

Table 75. Creative Biolabs Company Details

Table 76. Creative Biolabs Business Overview

Table 77. Creative Biolabs AI-based Antibody Development Platform Product

Table 78. Creative Biolabs Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)

Table 79. Creative Biolabs Recent Development

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

List of Figures

Figure 1. AI-based Antibody Development Platform Product Picture

Figure 2. Global AI-based Antibody Development Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global AI-based Antibody Development Platform Market Size 2019-2030 (US$ Million)

Figure 4. United States AI-based Antibody Development Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 5. United States AI-based Antibody Development Platform Market Size 2019-2030 (US$ Million)

Figure 6. United States AI-based Antibody Development Platform Market Share in Global 2019-2030

Figure 7. AI-based Antibody Development Platform Report Years Considered

Figure 8. Product Picture of Antibody Generation and Screening

Figure 9. Product Picture of Discovery and Target Recognition

Figure 10. Product Picture of Engineering and Optimization

Figure 11. Product Picture of Other

Figure 12. Global AI-based Antibody Development Platform Market Share by Type in 2023 & 2030

Figure 13. Global AI-based Antibody Development Platform Market Size by Type (2019-2030) & (US$ Million)

Figure 14. Global AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 15. United States AI-based Antibody Development Platform Market Share by Type in 2023 & 2030

Figure 16. United States AI-based Antibody Development Platform Market Size by Type (2019-2030) & (US$ Million)

Figure 17. United States AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 18. Product Picture of Pharmaceutical

Figure 19. Product Picture of Biotechnology

Figure 20. Product Picture of Academic Research

Figure 21. Product Picture of Others

Figure 22. Global AI-based Antibody Development Platform Market Share by Application in 2023 & 2030

Figure 23. Global AI-based Antibody Development Platform Market Size by Application (2019-2030) & (US$ Million)

Figure 24. Global AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 25. United States AI-based Antibody Development Platform Market Share by Application in 2023 & 2030

Figure 26. United States AI-based Antibody Development Platform Market Size by Application (2019-2030) & (US$ Million)

Figure 27. United States AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 28. The Top 5 and 10 Largest Companies of AI-based Antibody Development Platform in the World: Market Share by AI-based Antibody Development Platform Revenue in 2023

Figure 29. Global AI-based Antibody Development Platform Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 30. Global AI-based Antibody Development Platform Market Share by Region (2019-2030)

Figure 31. Americas AI-based Antibody Development Platform Market Size Growth Rate 2019-2030 (US$ Million)

Figure 32. Americas AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 33. Americas AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 34. United States AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 35. Canada AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 36. Mexico AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 37. Brazil AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 38. EMEA AI-based Antibody Development Platform Market Size Growth Rate 2019-2030 (US$ Million)

Figure 39. EMEA AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 40. EMEA AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 41. Europe AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 42. Middle East AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 43. Africa AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 44. China AI-based Antibody Development Platform Market Size Growth Rate 2019-2030 (US$ Million)

Figure 45. China AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 46. China AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 47. APAC AI-based Antibody Development Platform Market Size Growth Rate 2019-2030 (US$ Million)

Figure 48. APAC AI-based Antibody Development Platform Market Share by Type (2019-2030)

Figure 49. APAC AI-based Antibody Development Platform Market Share by Application (2019-2030)

Figure 50. Japan AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 51. South Korea AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 52. China Taiwan AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 53. ASEAN AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 54. India AI-based Antibody Development Platform Market Size Growth Rate (2019-2030) & (US$ Million)

Figure 55. Kyinno Biotechnolog Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 56. XtalPi Inc Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 57. DenovAI Biotech Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 58. immunitoAI Private Limited Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 59. EVQLV Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 60. Creative Biolabs Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI-based Antibody Development Platform market? zhanKai

The top companies in the global AI-based Antibody Development Platform market are Kyinno Biotechnolog、XtalPi Inc、DenovAI Biotech.

Related Reports

Global AI-based Antibody Development Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Antibody Development Platform market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 127
USD 4900.00
(Single User License)
Global AI-based Antibody Development Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Antibody Development Platform market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
AI-based Antibody Development Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Antibody Development Platform was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 89
USD 3950.00
(Single User License)
Global AI-based Antibody Development Platform Market Research Report 2026
The global AI-based Antibody Development Platform market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 109
USD 2900.00
(Single User License)
Global AI-based Antibody Development Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-based Antibody Development Platform market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global AI-based Antibody Development Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Antibody Development Platform market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 118
USD 4900.00
(Single User License)
AI-based Antibody Development Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Antibody Development Platform was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 83
USD 3950.00
(Single User License)
Global AI-based Antibody Development Platform Market Research Report 2025
The global market for AI-based Antibody Development Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 76
USD 2900.00
(Single User License)
Global AI-based Antibody Development Platform Market Research Report 2024
A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
Published Date: 2024-06-15
Pages: 76
USD 2900.00
(Single User License)
AI-based Antibody Development Platform- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
Published Date: 2024-06-15
Pages: 82
USD 3950.00
(Single User License)

Global AI-based Antibody Development Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Antibody Development Platform market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 127
USD 4900.00 (Single User License)
Global AI-based Antibody Development Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Antibody Development Platform market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
USD 4250.00 (Single User License)
AI-based Antibody Development Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Antibody Development Platform was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 89
USD 3950.00 (Single User License)
Global AI-based Antibody Development Platform Market Research Report 2026
The global AI-based Antibody Development Platform market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 109
USD 2900.00 (Single User License)
Global AI-based Antibody Development Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-based Antibody Development Platform market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)
Global AI-based Antibody Development Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Antibody Development Platform market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 118
USD 4900.00 (Single User License)
AI-based Antibody Development Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Antibody Development Platform was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 83
USD 3950.00 (Single User License)
Global AI-based Antibody Development Platform Market Research Report 2025
The global market for AI-based Antibody Development Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 76
USD 2900.00 (Single User License)
Global AI-based Antibody Development Platform Market Research Report 2024
A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
Published: 2024-06-15
Pages: 76
USD 2900.00 (Single User License)
AI-based Antibody Development Platform- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
Published: 2024-06-15
Pages: 82
USD 3950.00 (Single User License)